Tirzepatide vs. Retatrutide vs. Cagrilintide: A Research Peptide Comparison Guide

For laboratory and research use only. The information below is provided strictly for educational and scientific reference. None of these compounds are intended for human consumption, diagnosis, or treatment.

Among the metabolic research peptides studied today, three names come up again and again in scientific literature: Tirzepatide, Retatrutide, and Cagrilintide. Each belongs to a distinct mechanistic class, and understanding how they differ helps researchers design cleaner, better-controlled studies. This guide breaks down the science in plain language.

Receptor classes at a glance

The simplest way to tell these three research peptides apart is by the receptors they target in published studies:

• Tirzepatide — a dual GIP and GLP-1 receptor agonist. It is one of the most widely referenced peptides in incretin research. Explore the laboratory specifications on our Tirzepatide research peptide page.
• Retatrutide — a triple agonist acting on GIP, GLP-1, and glucagon receptors, making it a frequent subject in multi-pathway metabolic studies. See full details on the Retatrutide research peptide page.
• Cagrilintide — a long-acting amylin analog, often studied alongside incretin peptides in combination-research models. Specifications are available on the Cagrilintide research peptide page.

Why the differences matter in research

Because each peptide engages a different combination of receptors, the experimental endpoints researchers measure tend to differ. Single- and dual-pathway compounds like Tirzepatide are frequently used as comparison baselines, while triple agonists such as Retatrutide are studied for their broader receptor coverage. Amylin analogs like Cagrilintide are often examined for how they complement incretin pathways rather than duplicate them. Documenting which receptor class a compound belongs to is a basic requirement for reproducible study design.

Handling and reconstitution in the laboratory

All three are supplied as lyophilized (freeze-dried) powders and must be reconstituted before use in any research workflow. Most protocols call for bacteriostatic water as the reconstitution solution, added slowly down the side of the vial to protect the peptide structure. Reconstituted material is typically stored refrigerated and protected from light, with handling kept consistent across a study to reduce variability.

Choosing the right compound for a study

The right research peptide depends entirely on the receptor pathway being investigated. Researchers comparing incretin mechanisms often work with Tirzepatide; those exploring added glucagon-receptor activity look to Retatrutide; and those modeling amylin-pathway interactions turn to Cagrilintide. Many study designs include more than one of these compounds to draw direct mechanistic comparisons under identical laboratory conditions.

Research-grade quality

Every compound in the Regenwell PH catalog is supplied as a research-grade laboratory peptide for scientific use only. Browse the full range of research peptides available in the Philippines to compare specifications, vial sizes, and complete sets.

Reminder: These statements have not been evaluated for therapeutic use. Products are sold strictly for laboratory research and are not for human or animal consumption.